Arkolith/Insider Trading/CADL/Form 4

Aguilar Laura K.

10% OwnerCandel Therapeutics, Inc. (CADL) · full profile →Form 4 · filed Dec 6, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 6, 2024Disposed to issuer(D)20K$5.23$105K91K
Dec 5, 2024Disposed to issuer(D)20K$4.79$96K111K
Dec 4, 2024Disposed to issuer(D)20K$4.46$89K131K

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001873919-24-000008) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML